KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
20.29
+0.70 (3.57%)
At close: Apr 14, 2026, 4:00 PM EDT
20.29
0.00 (0.00%)
After-hours: Apr 14, 2026, 4:10 PM EDT
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts that cover KalVista Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $32.6, which forecasts a 60.67% increase in the stock price over the next year. The lowest target is $20 and the highest is $42.
Price Target: $32.6 (+60.67%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KalVista Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 3 | 3 | 4 | 3 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $39 → $42 | Strong Buy | Maintains | $39 → $42 | +107.00% | Mar 26, 2026 |
| Citizens | Citizens | Buy Maintains $29 → $28 | Buy | Maintains | $29 → $28 | +38.00% | Mar 26, 2026 |
| Needham | Needham | Strong Buy Maintains $35 → $36 | Strong Buy | Maintains | $35 → $36 | +77.43% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $37 | Strong Buy | Maintains | $27 → $37 | +82.36% | Jan 9, 2026 |
| Needham | Needham | Strong Buy Maintains $32 → $35 | Strong Buy | Maintains | $32 → $35 | +72.50% | Jan 9, 2026 |
Financial Forecast
Revenue This Year
211.42M
from 73.62M
Increased by 187.19%
Revenue Next Year
327.56M
from 211.42M
Increased by 54.93%
EPS This Year
-1.09
from -3.05
EPS Next Year
0.87
from -1.09
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 261.8M | 458.0M | |||
| Avg | 211.4M | 327.6M | |||
| Low | 178.7M | 228.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 255.6% | 116.6% | |||
| Avg | 187.2% | 54.9% | |||
| Low | 142.7% | 8.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.38 | 3.78 | |||
| Avg | -1.09 | 0.87 | |||
| Low | -1.28 | -0.38 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.